Gilbane Breaks Ground on Biopharmaceutical Manufacturing Facility in Norton, Massachusetts
The new 200,000 square foot, state-of-the art Facility Will Support Alnylam Pharmaceuticals Expanding Development Pipeline
Boston, MA – April 29, 2016 – State and Community officials, including Charlie Baker, the Governor of Massachusetts; Kimberly Haugstad, Executive Director of the Hemophilia Federation of America; Travis McCready, President and Chief Executive Officer of the Massachusetts Life Sciences Center and Lisa Nelson, Senior District Representative to U.S. Congressman Joseph Kennedy III, were in attendance to celebrate the official breaking of ground for Alnylam Pharmaceuticals, Inc. biopharmaceutical manufacturing facility in Norton, Massachusetts.
Gilbane will serve as construction manager for the new 200,000 square foot state-of-the-art manufacturing facility that will supply drug substance for RNAi (RNA interference) therapeutics for Alnylam’s clinical and commercial needs. The facility is expected to be operational in 2018 and will initially employ approximately 150 new full-time employees. The location of the new facility, selected in close collaboration with Commonwealth and local officials, demonstrates Alnylam’s ongoing commitment to Massachusetts.
“The energy and excitement at the event was contagious and it is sure to grow as the new facility develops from a vision into reality,” said Ryan Hutchins, Senior Vice President. “Construction involving biopharmaceutical facilities requires precision, vital documentation, compliance with stringent regulations and a superior commitment to safety. The team we have dedicated to this project have exceptional depth of experience constructing biopharmaceutical facilities. We are truly honored to be a part of Alnylam’s growth in Massachusetts.”
“We are excited to begin development of our new flagship multi-product manufacturing facility with the Gilbane team,” said Al Boyle, Senior Vice President, Technical Operations at Alnylam. “This facility represents a key next step in Alnylam’s transition toward a commercial stage company.”
About Gilbane Building Company
Gilbane provides a full slate of construction and facilities-related services – from pre-construction planning and integrated consulting capabilities to comprehensive construction management, close-out and facility management services – for clients across various markets. Founded in 1873 and still a privately held, family-owned company, Gilbane has more than 50 office locations around the world. For more information, visit www.gilbaneco.com.
Gilbane has been a leading Boston construction firm since 1946, serving commercial, institutional, and public clients in the Commonwealth including the Genzyme, Fraunhofer Center for Sustainable Energy Systems, University of Massachusetts, Worcester Polytechnic Institute, Tufts University, Verizon, Fidelity Investments, and Bank of America. The Boston office was recently named a Top Charitable Contributor in 2015 by Boston Business Journal. For more information, visit www.gilbaneco.com.
Rendering courtesy of Alnylam